Evaluating a Genetic Variant That Determines Response to Heart Disease Medications
This study will evaluate dogs with heart disease for a common genetic variant to determine whether this variant affects their ability to respond to heart medications.
Displaying 659 - 665 of 669 Results
Testing a New and Potentially Better Postsurgical Pain Strategy in Neutered Dogs
This study investigates better postsurgical pain-management strategies for dogs after castration.
Developing a Way to Predict Length of Disease-Free Intervals for Dogs with Bone Cancer
This study investigates how cytogenetic changes in canine osteosarcoma affect the duration of disease-free interval when patients are treated with amputation followed by doxorubicin and non-cytotoxic suramin.
Determining How Overexpression of miR-9 Helps Osteosarcoma Spread
This study will provide a molecular framework for understanding the process of miR-9-driven tumor spread in canine osteosarcoma, thereby generating potential new targets for therapy to prevent or treat tumor spread in this devastating disease.
Evaluating a Therapeutic Agent That May Inhibit a Protein Associated with Lymphoma
This study evaluates a new therapeutic agent designed to inhibit the survivin protein in canine lymphoma.
Understanding How Mammary Cancer Develops
This study investigates the role of citrullination in canine mammary cancer and how interfering with this process might lead to more effective anticancer treatments.
Identifying Genetic Mutations That Cause Extrahepatic Portosystemic Shunts in Dogs
This study will determine the genetic and functional differences of eight genes that are strongly associated with congenital extrahepatic portosystemic shunts in several small dog breeds.